Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.

Fabry disease is caused by deficient activity of α-galactosidase A (GLA) and characterized by systemic accumulation of glycosphingolipids, substrates of the enzyme. To gain insight into the pathogenesis of Fabry disease based on accumulated substrates, we examined the tissue and plasma distributions...

Full description

Bibliographic Details
Main Authors: Hideaki Sueoka, Mikio Aoki, Takahiro Tsukimura, Tadayasu Togawa, Hitoshi Sakuraba
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2015-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0144958&type=printable
_version_ 1826584313236291584
author Hideaki Sueoka
Mikio Aoki
Takahiro Tsukimura
Tadayasu Togawa
Hitoshi Sakuraba
author_facet Hideaki Sueoka
Mikio Aoki
Takahiro Tsukimura
Tadayasu Togawa
Hitoshi Sakuraba
author_sort Hideaki Sueoka
collection DOAJ
description Fabry disease is caused by deficient activity of α-galactosidase A (GLA) and characterized by systemic accumulation of glycosphingolipids, substrates of the enzyme. To gain insight into the pathogenesis of Fabry disease based on accumulated substrates, we examined the tissue and plasma distributions of globotriaosylceramide (Gb3) isoforms, and globotriaosylsphingosine (lyso-Gb3) and its analogues in a GLA knockout mouse, a model of Fabry disease, by means of liquid chromatography-mass spectrometry and nano-liquid chromatography-tandem mass spectrometry, respectively. The results revealed that the contents of these substrates in the liver, kidneys, heart, and plasma of GLA knockout mice were apparently higher than in those of wild-type ones, and organ specificity in the accumulation of Gb3 isoforms was found. Especially in the kidneys, accumulation of a large amount of Gb3 isoforms including hydroxylated residues was found. In the GLA knockout mice, the proportion of hydrophobic Gb3 isoforms was apparently higher than that in the wild-type mice. On the other hand, hydrophilic residues were abundant in plasma. Unlike that of Gb3, the concentration of lyso-Gb3 was high in the liver, and the lyso-Gb3/Gb3 ratio in plasma was significantly higher than those in the organs. The concentration of lyso-Gb3 was apparently higher than those of its analogues in the organs and plasma from both the GLA knockout and wild-type mice. This information will be useful for elucidating the basis of Fabry disease.
first_indexed 2024-12-21T15:59:17Z
format Article
id doaj.art-821538121ef84edc8cf92a3230b703bc
institution Directory Open Access Journal
issn 1932-6203
language English
last_indexed 2025-03-14T15:35:46Z
publishDate 2015-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj.art-821538121ef84edc8cf92a3230b703bc2025-02-25T05:32:55ZengPublic Library of Science (PLoS)PLoS ONE1932-62032015-01-011012e014495810.1371/journal.pone.0144958Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.Hideaki SueokaMikio AokiTakahiro TsukimuraTadayasu TogawaHitoshi SakurabaFabry disease is caused by deficient activity of α-galactosidase A (GLA) and characterized by systemic accumulation of glycosphingolipids, substrates of the enzyme. To gain insight into the pathogenesis of Fabry disease based on accumulated substrates, we examined the tissue and plasma distributions of globotriaosylceramide (Gb3) isoforms, and globotriaosylsphingosine (lyso-Gb3) and its analogues in a GLA knockout mouse, a model of Fabry disease, by means of liquid chromatography-mass spectrometry and nano-liquid chromatography-tandem mass spectrometry, respectively. The results revealed that the contents of these substrates in the liver, kidneys, heart, and plasma of GLA knockout mice were apparently higher than in those of wild-type ones, and organ specificity in the accumulation of Gb3 isoforms was found. Especially in the kidneys, accumulation of a large amount of Gb3 isoforms including hydroxylated residues was found. In the GLA knockout mice, the proportion of hydrophobic Gb3 isoforms was apparently higher than that in the wild-type mice. On the other hand, hydrophilic residues were abundant in plasma. Unlike that of Gb3, the concentration of lyso-Gb3 was high in the liver, and the lyso-Gb3/Gb3 ratio in plasma was significantly higher than those in the organs. The concentration of lyso-Gb3 was apparently higher than those of its analogues in the organs and plasma from both the GLA knockout and wild-type mice. This information will be useful for elucidating the basis of Fabry disease.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0144958&type=printable
spellingShingle Hideaki Sueoka
Mikio Aoki
Takahiro Tsukimura
Tadayasu Togawa
Hitoshi Sakuraba
Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.
PLoS ONE
title Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.
title_full Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.
title_fullStr Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.
title_full_unstemmed Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.
title_short Distributions of Globotriaosylceramide Isoforms, and Globotriaosylsphingosine and Its Analogues in an α-Galactosidase A Knockout Mouse, a Model of Fabry Disease.
title_sort distributions of globotriaosylceramide isoforms and globotriaosylsphingosine and its analogues in an α galactosidase a knockout mouse a model of fabry disease
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0144958&type=printable
work_keys_str_mv AT hideakisueoka distributionsofglobotriaosylceramideisoformsandglobotriaosylsphingosineanditsanaloguesinanagalactosidaseaknockoutmouseamodeloffabrydisease
AT mikioaoki distributionsofglobotriaosylceramideisoformsandglobotriaosylsphingosineanditsanaloguesinanagalactosidaseaknockoutmouseamodeloffabrydisease
AT takahirotsukimura distributionsofglobotriaosylceramideisoformsandglobotriaosylsphingosineanditsanaloguesinanagalactosidaseaknockoutmouseamodeloffabrydisease
AT tadayasutogawa distributionsofglobotriaosylceramideisoformsandglobotriaosylsphingosineanditsanaloguesinanagalactosidaseaknockoutmouseamodeloffabrydisease
AT hitoshisakuraba distributionsofglobotriaosylceramideisoformsandglobotriaosylsphingosineanditsanaloguesinanagalactosidaseaknockoutmouseamodeloffabrydisease